Polysulfides Protect SH-SY5Y Cells from Methylglyoxal-induced Toxicity by Suppressing Protein Carbonylation: A Possible Physiological Scavenger for Carbonyl Stress in the Brain
Overview
Neurology
Toxicology
Authors
Affiliations
The formation of advanced glycation end products (AGEs) is associated with various neurological disorders, such as Alzheimer's disease, Parkinson's disease and schizophrenia. Methylglyoxal (MG), a highly reactive dicarbonyl compound, is known to be a major precursor for AGEs in modified proteins. Thus, a scavenger of MG might provide beneficial effects by suppressing the accumulation of AGEs and the occurrence of diseases induced by carbonyl stress. Meanwhile, polysulfides, one of the typical bound sulfur species, are oxidized forms of hydrogen sulfide (H2S) and may play a variety of roles in the brain. Herein, we assessed the scavenging ability of polysulfides against neuronal carbonyl stress induced by MG. First, we showed that polysulfides could protect differentiated (df)-SH-SY5Y cells from MG-induced cytotoxicity. When cells were pretreated with polysulfides, MG-induced cytotoxicity was attenuated with a rapid decrease in intracellular MG levels. Moreover, we found that polysulfides significantly suppressed the formation of MG-modified proteins in df-SH-SY5Y cells. Although polysulfide treatment increased endogenous GSH levels in the neuronal cells, its effects on MG-induced cytotoxicity were not affected by GSH concentration. Our results demonstrated that polysulfides had the direct potentials to protect neuronal cells against MG separate to the enzymatic detoxification system that required GSH.
Koike S, Kimura H, Ogasawara Y Redox Biol. 2024; 79():103450.
PMID: 39667306 PMC: 11697784. DOI: 10.1016/j.redox.2024.103450.
Koike S, Tsurudome S, Okano S, Kishida A, Ogasawara Y Neurochem Res. 2024; 50(1):28.
PMID: 39576418 DOI: 10.1007/s11064-024-04255-0.
Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma .
Du R, Sanin A, Shi W, Huang B, Nickel A, Vargas-Toscano A Front Pharmacol. 2024; 15:1468920.
PMID: 39386028 PMC: 11461351. DOI: 10.3389/fphar.2024.1468920.
Aschner M, Skalny A, Ke T, da Rocha J, Paoliello M, Santamaria A Curr Neuropharmacol. 2022; 20(10):1908-1924.
PMID: 35236265 PMC: 9886801. DOI: 10.2174/1570159X20666220302101854.
Koike S, Toriumi K, Kasahara S, Kibune Y, Ishida Y, Dan T Antioxidants (Basel). 2021; 10(4).
PMID: 33917901 PMC: 8068291. DOI: 10.3390/antiox10040574.